11. It takes a team for HCC: The adverse events reduction in first line HCC systemic therapies with the multidisciplinary ambulatory. (March 2023) Authors: Dalbeni, A.; Auriemma, A.; Vicardi, M.; Ruzzenente, A.; Guglielmi, A.; Milella, M.; Sacerdoti, D. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Letter: chronic hepatitis C genotype 3 infection – still a hurdle toward a direct‐acting anti‐viral‐induced HCV cure?. Issue 10 (17th April 2017) Authors: Bruno, G.; Milella, M.; Angarano, G.; Saracino, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 10(2017) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Letter: chronic hepatitis C genotype 3 infection – still a hurdle toward a direct‐acting anti‐viral‐induced HCV cure?. Issue 10 (May 2017) Authors: Bruno, G.; Milella, M.; Angarano, G.; Saracino, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 10(2017) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A "real life" study. (February 2017) Authors: Giordano, G.; Lo Re, G.; Milella, M.; Di Marco, M.; Melisi, D.; Passardi, A.; Iop, A.; Febbraro, A.; Foltran, L.; Francesca, B.; Bertocchi, P.; Vaccaro, V.; Aloi, M.B.; Giommoni, E.; Ricci, V.; Vasile, E.; Zaniboni, A.; Zagone, V.; De Vita, F. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Numerical approach to the study of coastal boulders: The case of Martigues, Marseille, France. (22nd May 2017) Authors: Piscitelli, A.; Milella, M.; Hippolyte, J.-C.; Shah-Hosseini, M.; Morhange, C.; Mastronuzzi, G. Journal: Quaternary international Issue: Volume 439(2017)Part A Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. P-147Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile?. (24th June 2015) Authors: Fornaro, L.; Vivaldi, C.; Brandi, G.; Cereda, S.; Aprile, G.; Santini, D.; Silvestris, N.; Lonardi, S.; Leone, F.; Milella, M.; Caparello, C.; Musettini, G.; Pasquini, G.; Vasile, E. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 4 Page Start: iv42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. P.04.4 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH SURVIVAL OF PATIENTS WITH PANCREATIC CANCER. Issue 2 (15th March 2018) Authors: Stornello, C.; Archibugi, L.; Stigliano, S.; Signoretti, M.; Vanella, G.; Capalbo, C.; Nigri, G.; Milella, M.; Capurso, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. PO-138 Prognostic value of tailored nutritional support in Head and Neck cancer patients undergoing treatments. (March 2019) Authors: Tondulli, L.; Trestini, I.; Carbognin, L.; Sperduti, I.; Bonaiuto, C.; Pilotto, S.; Tortora, G.; Milella, M.; Bria, E. Journal: Radiotherapy and oncology Issue: Volume 132(2019)Supplement 1 Page Start: 73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Issue 2 (1st February 2021) Authors: Mennitto, A.; Verzoni, E.; Cognetti, F.; Miceli, R.; Milella, M.; Mosca, A.; Chiuri, V. E.; Bearz, A.; Morelli, F.; Ortega, C.; Atzori, F.; Donini, M.; Claps, M.; Guadalupi, V.; Sepe, P.; Cappelletti, V.; de Braud, F. G.; Procopio, G. Journal: Expert review of clinical pharmacology Issue: Volume 14:Issue 2(2021) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Rapid improvement in liver fibrosis in HCV‐infected patients with or without HIV infection and DAA‐induced SVR: A "turning‐off" effect of liver inflammation?. Issue 2 (14th November 2016) Authors: Bruno, G.; Saracino, A.; Fabrizio, C.; Scudeller, L.; Milella, M.; Angarano, G. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 2(2017) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗